TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Galena Pharma Oy
Closing information (x1000 EUR)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
3,727
|
3,181 | |
Financial expenses |
1
|
10
|
11 |
Earnings before taxes |
355
|
21
|
219 |
Total assets |
2,060
|
1,603
|
1,390 |
Current assets |
183
|
203
|
878 |
Current liabilities |
1,044
|
1,134
|
644 |
Equity capital |
666
|
368
|
547 |
- share capital |
326
![]() |
326
![]() |
326 |
Employees (average) |
25
|
20
|
19 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
32.3%
|
23.0%
|
39.4% |
Turnover per employee |
186
|
167 | |
Profit as a percentage of turnover |
0.6%
|
6.9% | |
Return on assets (ROA) |
17.3%
|
1.9%
|
16.5% |
Current ratio |
17.5%
|
17.9%
|
136.3% |
Return on equity (ROE) |
53.3%
|
5.7%
|
40.0% |
Change turnover |
546
|
414 | |
Change turnover % |
17%
|
15% | |
Chg. No. of employees |
5
|
1
|
0 |
Chg. No. of employees % |
25%
|
5%
|
0% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.